ContraFect Announces Funding Agreement with the Cystic Fibrosis Foundation YONKERS, New York, Aug. 25, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...

TransPerfect’s Colleen Chulis Honored as Charlottesville’s Finest by the Cystic Fibrosis Foundation NEW YORK, June 29, 2016 (GLOBE NEWSWIRE) -- TransPerfect, the world's largest privately held provider of language services and translation-related technologies, today announced that Colleen...